Potential contribution of 131I-Labelled monoclonal anti-CEA antibodies in the treatment of liver metastases from colorectal carcinomas: Pretherapeutic study with dose recovery in resected tissues

This publication has 15 references indexed in Scilit:

• Treatment of metastatic colorectal cancer by means of specific monoclonal antibodies conjugated with iodine-131: a phase II study
  International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1991
• MIRD Primer for Absorbed Dose Calculations
  Clinical Nuclear Medicine, 1989
• Ablation of human colon carcinoma in nude mice by 131I-labeled monoclonal anti-carcinoembryonic antigen antibody F(ab')2 fragments.
  Journal of Clinical Investigation, 1989
• Intraperitoneal radioimmunotherapy for ovarian cancer: Pharmacokinetics, toxicity, and efficacy of I-131 labeled monoclonal antibodies
  International Journal of Radiation Oncology*Biology*Physics, 1989
• Progress in Diagnostic Immunoscintigraphy and First Approach to Radioimmunotherapy of Colon Carcinoma
  Published by Springer Nature ,1988
• Localization of Radioiodinated Monoclonal Antibody in Colorectal Cancer
  Archives of Surgery, 1987
• 90Yttrium antiferritin—a new therapeutic radiolabeled antibody
  International Journal of Radiation Oncology*Biology*Physics, 1986
• Detection of colorectal carcinoma by emission-computerized tomography after injection of 123I-labeled Fab or F(ab')2 fragments from monoclonal anti-carcinoembryonic antigen antibodies.
  Journal of Clinical Investigation, 1986
• Localization of 131I-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapy.
  Journal of Clinical Investigation, 1983
• Tumor Localization of Radio-Labeled Antibodies against Carcinoembryonic Antigen in Patients with Carcinoma
  New England Journal of Medicine, 1980